Data Characteristics
Small molecule drug R&D data originates primarily from preclinical research reports, clinical trial protocols and reports, drug registration dossiers, patent literature, and scientific papers. These documents update infrequently, typically on a periodic basis as research phases advance or regulatory requirements change. Document structures are highly complex, containing extensive specialized terminology, chemical structures, experimental data tables, spectra, pharmacokinetic curves, and statistical analysis results. Fields include drug names, molecular formulas, CAS numbers, target information, mechanisms of action, dosages, administration routes, pharmacodynamics, pharmacokinetic parameters (e.g., Cmax, AUC, t1/2), and toxicology data. Units adhere to international standards, such as mg/kg, µg/mL, nM, and h.
Constraints Imposed by These Characteristics on Vector Models and Indexing
The complex structure and specialized nature of small molecule drug R&D documents impose specific requirements on vector models and indexing. First, traditional text vector models struggle to effectively encode the semantics of chemical structures and spectra within documents, limiting retrieval accuracy. Second, various experimental data tables and statistical results require the ability to identify and extract key numerical values and units, ensuring precise quantitative information is associated during retrieval. The dense use of specialized terminology demands high-dimensional semantic understanding from vector models to avoid recall omissions due to lexical differences. Low update frequency means indexing reconstruction costs are relatively manageable, but each update requires accurate and timely incremental indexing. The richness of fields necessitates multi-dimensional retrieval capabilities, allowing filtering or sorting based on specific parameters, such as by Cmax range or t1/2.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 800–1200 characters | Ensures each segment contains sufficient context to understand specific experimental descriptions or conclusions in small molecule drugs, while preventing individual segments from being too long and diluting key information. |
Overlap Length | 100–200 characters | Guarantees semantic coherence across segments, especially in descriptive content like chemical reaction steps or pharmacological mechanisms, helping to capture complete semantics. |
Embedding Model | multimodal-embedding-v1 or text-embedding-ada-002 | multimodal-embedding-v1 can process some charts and structural information, enhancing comprehensive retrieval capabilities; for pure text scenarios, text-embedding-ada-002 offers a balance of performance and cost. |
Recall count (Recall Count) | Top 10–15 items | Given the complexity of R&D documents, appropriately increasing the recall count improves recall rate, providing more candidates for the subsequent reranking model to select from. |
Similarity threshold (Similarity Threshold) | Calibrated by actual measurement | Requires testing with actual R&D query corpora, balancing recall and precision based on business needs, typically adjusted between 0.75–0.85. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Small molecule drug R&D documents are often large and structurally complex, requiring longer parsing times. Extending the timeout appropriately prevents parsing interruptions. |
Common Pitfalls
- Retrieval results contain many irrelevant or low-quality segments: Failure to effectively identify key entities and data in documents leads to low-quality vectorization, or the
similarity thresholdis set too loosely. - Document indexing takes too long, or timeout errors occur: The
PARSE_FILE_TIMEOUT_SECONDSconfiguration is insufficient to handle large or structurally complex PDF or Word documents, or the document parser has poor support for specific formats. - Document content containing chemical structures or charts is not effectively retrieved: The selected vector model is primarily text-oriented, with limited understanding of image or non-textual information, leading to insufficient representation of these key pieces of information in the vector space.
Validation Steps
- Perform a series of queries involving specialized terminology, chemical names, and pharmacokinetic parameters. Check if recall results accurately include relevant document segments and evaluate if the relevance of recalled items to query intent meets expected thresholds.
- Upload and index multiple typical small molecule drug R&D documents (e.g., clinical trial reports). Monitor indexing process logs to confirm no timeouts or parsing failure errors, and check if document status is normal after indexing completion.
- Use queries containing charts or structures. Verify if retrieval results can effectively link to document segments containing this visual information, validating the effectiveness of the multimodal embedding model (if used).
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.